FLoRA Replication Atlas › Browse

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

Katherine D LaClair, Kebreten F Manaye, Dexter L Lee, Joanne S Allard, Alena V Savonenko, Juan C Troncoso, Philip C Wong

Molecular Neurodegeneration, 2013. DOI 10.1186/1750-1326-8-18

Has this study been replicated?

This paper is itself a replication attempt. The study it set out to replicate is listed below.

Study replicated

• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models, Cramer et al. (2012). Science. View paper

Cite this record

LaClair, K. D., Manaye, K. F., Lee, D. L., Allard, J. S., Savonenko, A. V., Troncoso, J. C., & Wong, P. C. (2013). Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Molecular Neurodegeneration, 8(1). https://doi.org/10.1186/1750-1326-8-18

Other studies in the atlas

• A replication of "an experimental test of the expectancy‐disconfirmation theory of…
• Do Voters Affect or Elect Policies? Evidence from the U. S. House
• Elasticities of substitution between marketing and farm inputs in a complete system of…
• The effects of Taiwan's National Health Insurance on access and health status of the…
• Replication of acne susceptibility loci and gene–environment interactions with screen…
• Revisiting Covin and Slevin (1989): Replication and extension of the relationship…

Failed replications · Successful replications · All browse pages